Literature DB >> 15246744

Werner syndrome protein 1367 variants and disposition towards coronary artery disease in Caucasian patients.

Vilhelm A Bohr1, E Jeffery Metter, Jeanine A Harrigan, Cayetano von Kobbe, Ji Lan Liu, Matthew D Gray, Alokes Majumdar, David M Wilson, Michael M Seidman.   

Abstract

The leading causes of death for individuals with Werner syndrome (WS) are myocardial infarction (MI) and stroke. The WS gene encodes a nuclear protein with both helicase and exonuclease activities. While individuals with WS have mutations that result in truncated, inactive proteins, several sequence variants have been described in apparently unaffected individuals. Some of these gene polymorphisms encode non-conservative amino acid substitutions, and it is expected that the changes would affect enzyme activity, although this has not been determined. Two research groups have studied the Cys/Arg 1367 polymorphism (located near the nuclear localization signal) in healthy and MI patients. Their results suggest that the Arg allele is protective against MI. We have characterized the Cys (C) and Arg (R) forms of the protein and find no notable difference in helicase and nuclease activities, or in nuclear/cytoplasmic distribution. The frequency of the C/R alleles in healthy individuals and subjects with coronary artery disease (CAD) drawn from the Baltimore Longitudinal Study of Aging (BLSA) was also examined. There was no indication that the R allele was protective against CAD. We conclude that the C/R polymorphism does not affect enzyme function or localization and does not influence CAD incidence in the BLSA cohort.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15246744     DOI: 10.1016/j.mad.2004.05.001

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  12 in total

Review 1.  Mechanisms of RecQ helicases in pathways of DNA metabolism and maintenance of genomic stability.

Authors:  Sudha Sharma; Kevin M Doherty; Robert M Brosh
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

2.  The Werner's syndrome 4330T>C (Cys1367Arg) gene variant does not affect the in vitro cytotoxicity of topoisomerase inhibitors and platinum compounds.

Authors:  Federico Innocenti; Snezana Mirkov; Ramamoorthy Nagasubramanian; Jacqueline Ramírez; Wanqing Liu; Wasim K Bleibel; Sunita J Shukla; Kathleen Hennessy; Gary L Rosner; Edwin Cook; M Eileen Dolan; Mark J Ratain
Journal:  Cancer Chemother Pharmacol       Date:  2008-08-02       Impact factor: 3.333

Review 3.  The quest for genetic determinants of human longevity: challenges and insights.

Authors:  Kaare Christensen; Thomas E Johnson; James W Vaupel
Journal:  Nat Rev Genet       Date:  2006-06       Impact factor: 53.242

Review 4.  The clinical characteristics of Werner syndrome: molecular and biochemical diagnosis.

Authors:  Meltem Muftuoglu; Junko Oshima; Cayetano von Kobbe; Wen-Hsing Cheng; Dru F Leistritz; Vilhelm A Bohr
Journal:  Hum Genet       Date:  2008-09-23       Impact factor: 4.132

5.  WRN Cys1367Arg SNP is not associated with risk and prognosis of gliomas in Southeast Brazil.

Authors:  Giovanny R Pinto; France K N Yoshioka; Carlos A Clara; Marcelo J Santos; José R W Almeida; Rommel R Burbano; Juan A Rey; Cacilda Casartelli
Journal:  J Neurooncol       Date:  2008-08-01       Impact factor: 4.130

Review 6.  Roles of Werner syndrome protein in protection of genome integrity.

Authors:  Marie L Rossi; Avik K Ghosh; Vilhelm A Bohr
Journal:  DNA Repair (Amst)       Date:  2010-01-13

7.  Polymorphisms of the WRN gene and DNA damage of peripheral lymphocytes in age-related cataract in a Han Chinese population.

Authors:  Shengqun Jiang; Nan Hu; Jing Zhou; Junfang Zhang; Ruifang Gao; Jianyan Hu; Huaijin Guan
Journal:  Age (Dordr)       Date:  2013-01-20

8.  Lack of association of the WRN C1367T polymorphism with senile cataract in the Israeli population.

Authors:  M Ehrenberg; O Dratviman-Storobinsky; B R Avraham-Lubin; N Goldenberg-Cohen
Journal:  Mol Vis       Date:  2010-08-28       Impact factor: 2.367

Review 9.  From old organisms to new molecules: integrative biology and therapeutic targets in accelerated human ageing.

Authors:  L S Cox; R G A Faragher
Journal:  Cell Mol Life Sci       Date:  2007-10       Impact factor: 9.261

Review 10.  Human premature aging, DNA repair and RecQ helicases.

Authors:  Robert M Brosh; Vilhelm A Bohr
Journal:  Nucleic Acids Res       Date:  2007-11-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.